4.7 Article

Differential expression of an endogenous retroviral element [HERV-K(HML-6)] is associated with reduced survival in glioblastoma patients

Related references

Note: Only part of the references are listed.
Review Oncology

Human endogenous retroviruses in cancer: Expression, regulation and function

Yuan Gao et al.

Summary: This review examines the expression patterns and regulatory mechanisms of HERVs in cancer, highlighting their dual roles in either suppressing or promoting cancer through immune activation or immune suppression. HERV env gene plays a key role in promoting carcinogenesis in certain malignant tumors, and targeting ENV proteins could be a potential future antitumor treatment approach.

ONCOLOGY LETTERS (2021)

Review Chemistry, Medicinal

Endogenous Retroviruses in Nervous System Disorders

Victoria Groger et al.

Summary: Human endogenous retroviruses (HERV) have been linked to the pathogenesis of neurological disorders such as multiple sclerosis and amyotrophic lateral sclerosis. Inhibiting HERV activities could potentially lead to new treatment strategies for currently incurable diseases.

PHARMACEUTICALS (2021)

Article Immunology

Regulation of the expression of human endogenous retroviruses: elements in fetal development and a possible role in the development of cancer and neurological diseases

Maiken Kruse Kristensen et al.

Summary: HERVs are remnants of ancient retroviral germline infections in humans, with potential roles in both health and disease, including various cancer types and neurological diseases. Understanding the regulation of HERVs can contribute to the comprehension of complex pathogeneses and may lead to potential targets for better diagnosis and treatment in diseases such as multiple sclerosis.

APMIS (2021)

Article Oncology

Locus-Specific Characterization of Human Endogenous Retrovirus Expression in Prostate, Breast, and Colon Cancers

Margaret C. Steiner et al.

Summary: Research implicates that HERVs are involved in various cancers, with differential expression identified in prostate, breast, and colon cancers. The study highlights potential biomarkers and therapeutic targets in these cancers, providing insights into the role of HERVs in cancer pathogenesis.

CANCER RESEARCH (2021)

Article Oncology

The role of human endogenous retroviruses in gliomas: from etiological perspectives and therapeutic implications

Ashish H. Shah et al.

Summary: HERVs, accounting for approximately 8% of the human genome, have been implicated in various cancers including gliomas. While they may contribute to oncogenesis through multiple mechanisms, recent data suggests that reversing their epigenetic silencing could induce robust anti-tumor immune responses, potentially serving as a therapeutic target for gliomas. Leveraging this anti-tumor autoimmune response may provide a unique avenue for treating epigenetically-dysregulated gliomas.

NEURO-ONCOLOGY (2021)

Article Multidisciplinary Sciences

SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression

Tara T. Doucet-O'Hare et al.

Summary: AT/RT is a rare pediatric CNS cancer often associated with SMARCB1 mutations. This study shows that SMARCB1 regulates HML-2 expression, which in turn affects cell proliferation and gene signaling pathways in AT/RT. The activation of HML-2, dependent on SMARCB1 and its interaction with MYC, may play a crucial role in the pluripotency and formation of these undifferentiated tumors.

SCIENTIFIC REPORTS (2021)

Review Biochemistry & Molecular Biology

IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications?

Alisan Kayabolen et al.

Summary: The discovery of mutations in IDH genes in gliomas a decade ago has challenged our understanding of the role of metabolism in tumor progression. These mutations are common in lower grade gliomas and secondary glioblastomas, driving tumorigenesis. Inhibiting mutant IDH enzymes is seen as a promising therapeutic strategy, while exploiting the vulnerabilities caused by these mutations may offer another attractive approach.

BIOMEDICINES (2021)

Review Biochemistry & Molecular Biology

Human Endogenous Retroviruses as Gene Expression Regulators: Insights from Animal Models into Human Diseases

Serpen Durnaoglu et al.

Summary: The human genome contains HERVs, retroviral elements integrated throughout evolution, which actively regulate gene expression in various physiological and pathological conditions. Recent studies show HERVs are activated in COVID-19 patients. Understanding the role of HERVs in different processes can help develop therapeutic strategies targeting HERVs.

MOLECULES AND CELLS (2021)

Article Biochemical Research Methods

Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression

Matthew L. Bendall et al.

PLOS COMPUTATIONAL BIOLOGY (2019)

Review Microbiology

HERVs New Role in Cancer: From Accused Perpetrators to Cheerful Protectors

Norbert Bannert et al.

FRONTIERS IN MICROBIOLOGY (2018)

Article Biochemistry & Molecular Biology

Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses

Katherine B. Chiappinelli et al.

Article Biotechnology & Applied Microbiology

Transcriptional Activity of Human Endogenous Retroviruses in Human Peripheral Blood Mononuclear Cells

Emanuela Balestrieri et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Review Immunology

Endogenous Retroviruses and the Development of Cancer

George Kassiotis

JOURNAL OF IMMUNOLOGY (2014)

Review Biotechnology & Applied Microbiology

Specific primer design for the polymerase chain reaction

Li-Yeh Chuang et al.

BIOTECHNOLOGY LETTERS (2013)

Review Medicine, Research & Experimental

The role of human endogenous retroviral long terminal repeat sequences in human cancer

Hong-Lian Yu et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)

Article Genetics & Heredity

Endogenous retroviruses function as species-specific enhancer elements in the placenta

Edward B. Chuong et al.

NATURE GENETICS (2013)

Article Oncology

HERV-K and LINE-1 DNA methylation and reexpression in urothelial carcinoma

Ulrike Kreimer et al.

FRONTIERS IN ONCOLOGY (2013)

Article Biochemistry & Molecular Biology

Primer3-new capabilities and interfaces

Andreas Untergasser et al.

NUCLEIC ACIDS RESEARCH (2012)

Review Biochemistry & Molecular Biology

Human endogenous retroviruses and multiple sclerosis: Innocent bystanders or disease determinants?

Joseph M. Antony et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)

Review Oncology

Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer

M. T. Romanish et al.

SEMINARS IN CANCER BIOLOGY (2010)

Review Virology

Molecular mechanisms mediated by Human Endogenous Retroviruses (HERVs) in autoimmunity

Eva Balada et al.

REVIEWS IN MEDICAL VIROLOGY (2009)

Article Immunology

Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma

S Rakoff-Nahoum et al.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)

Article Biochemistry & Molecular Biology

L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas

Laura Menendez et al.

MOLECULAR CANCER (2004)

Article Multidisciplinary Sciences

Retroelements and the human genome: New perspectives on an old relation

N Bannert et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)